The Deputy Health Minister of Tatarstan F. Yarkaeva together with the Head of the Department for Organization of Work of Pharmaceutical Agencies and Enterprises under the City Administration’s Health Committee L. Sychevskaya made an official visit to the special economic zone “Neudorf” on August 3. Among top visiting points was the R&D center of GEROPHARM – Pharm-Holding.
Today special economic zones are important institutions that have influence on the country’s development as they include various companies that carry out promising high-tech projects in key sectors of the economy. World-class R&D center Pharm-Holding is a growth point of GEROPHARM Group. The development of drugs on full cycle principle: from the substance synthesis to finished dosage form, testing and implementation of products on industrial production are carried out here.
According to the Director of R&D center Lola Maksumova: “There are 15 projects on various stages of implementation, 2 of them, which are focused on insulin lispro and lispro biphasic development, have been already implemented under a state contract with the Ministry of Industry and Trade of the Russian Federation. A full pipeline of analogue insulins is planned to be introduced to the market by 2019”.
As a part of official visit a productive dialogue between the representatives of public contracting authorities and business community was held. The Economic Security Director of GEROPHARM Andrey Ahantiev noted that a considerable work on the development of a number of measures to stimulate domestic manufacturers has been done thanks to the joint efforts of the Ministry of Health and Ministry of Trade and Industry. The customers have almost no doubts about the quality of local drugs. That was confirmed by the guests during their visit. However, today, the key issue for GEROPHARM Group is the opportunity to participate fully in public procurement, where, unfortunately, some violations of the law on Contract System, Resolution of the Government №1289, preventing the admission of local producers to trading, are observed. The representatives of the Ministry of Health of Tatarstan and Health Committee of St. Petersburg noted that it is necessary to work with medical and patient community and change public attitude towards the drugs of local production more actively.